IVERIC bio, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2014 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
IVERIC bio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2014 to Q1 2023.
  • IVERIC bio, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
  • IVERIC bio, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was $0.000.
  • IVERIC bio, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • IVERIC bio, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
  • IVERIC bio, Inc. annual Income Tax Expense (Benefit) for 2020 was -$3.7M, a 3229% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $0 $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $0 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $0 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-07-26
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $0 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $0 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $0 $0 +$386K Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-26
Q1 2021 -$386K $0 +$3.31M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$3.7M $0 -$5K -100% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$3.69M $0 +$125K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$3.82M -$386K -$390K -9750% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$3.43M -$3.31M -$3.31M -66280% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$111K $5K +$237K Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$348K -$125K -$131K -2183% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 -$217K $4K +$1.04M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$1.26M $5K -$195K -97.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$1.06M -$232K +$4.68M +95.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-04
Q3 2018 -$5.74M $6K -$188K -96.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$5.55M -$1.04M -$1.04M -103600% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$4.52M $200K +$197K +6567% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$4.71M -$4.91M -$4.66M -1879% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$52K $194K +$124K +177% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 -$176K -$1K +$259K +99.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$435K $3K -$29K -90.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$406K -$248K +$4.91M +95.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$5.32M $70K +$7.6M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$12.9M -$260K +$4.81M +94.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$17.7M $32K -$942K -96.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$16.8M -$5.16M -$5.67M -1107% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-05
Q3 2015 -$11.1M -$7.53M -$12.7M -245% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $1.59M -$5.07M -$35.9M -116% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $37.5M $974K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $512K Oct 1, 2014 Dec 31, 2014 10-K/A 2015-07-28
Q3 2014 $5.18M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $30.8M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.